A standard MRI scan cannot diagnose ALS on its own, and in many cases, the brain of someone with ALS looks unremarkable on routine imaging. That disconnect is one reason the disease takes so long to confirm, often a year or more from first symptoms. Yet MRI is far from irrelevant. It serves two critical functions: ruling out conditions that mimic ALS (tumors, spinal cord compression, multiple sclerosis) and, with newer techniques, revealing subtle patterns of degeneration that increasingly point toward ALS when combined with clinical findings. The story of MRI in ALS is less about a single scan delivering a verdict and more about an evolving toolkit that is slowly closing the diagnostic gap.
What a Routine Brain MRI Can and Cannot Show
When a neurologist orders a brain MRI for someone suspected of having ALS, the primary goal is often exclusion. The scan checks for structural problems that could explain the symptoms: a cervical disc compressing the spinal cord, a tumor in the motor cortex, inflammatory lesions suggestive of multiple sclerosis. If those are absent, the MRI has done its most straightforward job. But the scan is not entirely blank in ALS patients. On a type of MRI sequence called FLAIR, bright signals can sometimes appear along the corticospinal tract, the highway of nerve fibers connecting the brain’s motor cortex to the spinal cord. One study found that this corticospinal tract hyperintensity was significantly more common in ALS patients than in healthy controls at multiple levels, from the cortex down through the brainstem.1PubMed. Hyperintensity of the corticospinal tract on FLAIR: A simple and sensitive objective upper motor neuron degeneration marker in clinically verified amyotrophic lateral sclerosis
The catch is that this bright signal is neither universal nor unique to ALS. Some healthy people show it. And in those who do have ALS, the signal doesn’t reliably change over time, which limits its usefulness for tracking progression.2PubMed. Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images A radiologist reading a routine brain MRI might note the hyperintensity and flag it as consistent with motor neuron disease, but that observation alone won’t seal a diagnosis. It’s a clue, not a fingerprint.
The Motor Band Sign
One of the more promising visual markers on MRI is the “motor band sign,” a dark stripe that appears along the precentral gyrus (the brain’s primary motor strip). This hypointensity is thought to reflect iron accumulation in degenerating motor neurons, and it shows up best on certain susceptibility-weighted MRI sequences. A systematic review described it as a radiologic hallmark of ALS that is detected in the majority of motor neuron disease patients when susceptibility-weighted imaging is used.3Acta Neurologica Scandinavica. Motor Band Sign in Motor Neuron Diseases Using Magnetic Resonance Imaging: A Systematic Review
A study comparing ALS patients to both ALS mimics and healthy controls put more precise numbers on it. The motor band sign appeared in about 60% of ALS patients, compared to roughly 9% of people with conditions that look like ALS and about 3% of healthy controls. That translated to a specificity above 91% against mimics, meaning if the sign is present, there is a strong chance the person actually has ALS rather than a lookalike condition.4PubMed Central. Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptoms The trade-off is sensitivity: because only about 60% of ALS patients show the sign, its absence doesn’t rule ALS out. This is a recurring theme in ALS imaging. The findings tend to be fairly specific when they do appear, but they are not present in everyone with the disease.
Diffusion Tensor Imaging and White Matter Breakdown
Conventional MRI sees structure. Diffusion tensor imaging, or DTI, sees how water moves through brain tissue, which reveals the health of nerve fiber tracts that are invisible on a standard scan. In healthy white matter, water flows preferentially along the direction of the fibers, like traffic on a highway. When those fibers degenerate, water scatters in all directions. Researchers quantify this directionality with a measure called fractional anisotropy (FA). Lower FA means more disorganized tissue.
In ALS, FA is consistently reduced along the corticospinal tract. One early study demonstrated that FA dropped progressively from the upper brainstem down to the lower brainstem in ALS patients and was lower than in controls at multiple levels.5PubMed Central. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis A separate study confirmed that FA along the corticospinal tract decreased as clinical signs of upper motor neuron damage worsened.6PubMed. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation
What makes DTI especially interesting is its ability to track the disease over time. A large multicentre longitudinal study found that FA reductions were already present at baseline in the corticospinal tract and corpus callosum and continued to decline over subsequent visits. The decline was greatest in the lower portions of the corticospinal tract, and the degree of reduction correlated with functional impairment and disease progression rate.7NeuroImage: Clinical. Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging study DTI is not yet used as a standalone diagnostic tool, but it captures white matter damage that standard MRI misses and is among the most promising candidates for a future imaging biomarker.
Cervical Spinal Cord Imaging
ALS attacks both the brain and the spinal cord, so scanning the cord itself can add information. The cervical spinal cord, the segment running through the neck, is especially relevant because it houses the motor neurons supplying the arms and hands, often among the first areas affected. A meta-analysis found that people with ALS have significantly reduced cross-sectional area along the entire cervical cord compared to controls, with the most pronounced thinning in the C4 to C6 region, the cervical enlargement that feeds the upper limbs. FA was also significantly decreased, and overall water diffusion was increased, both reflecting tissue breakdown.8PubMed Central. Cervical spinal cord MRI in ALS individuals: a systematic review and meta-analysis
What’s interesting is that spinal cord changes show up even in the earliest clinical stages. A study that staged patients found that those in the earliest clinical phase already had significant changes in the cord’s gray matter, while patients at later stages showed involvement of both gray and white matter.9PubMed Central. Cervical spinal cord atrophy in amyotrophic lateral sclerosis across disease stages Spinal cord MRI is technically challenging (the cord moves with every heartbeat and breath), but improvements in imaging protocols are making it more practical. For a patient whose symptoms start in the arms, cord imaging can add a layer of objective evidence that the clinical exam alone may not fully capture.
Spectroscopy and the Chemistry of Neuronal Loss
Magnetic resonance spectroscopy (MRS) does something entirely different from structural MRI: it measures the chemical makeup of brain tissue. The chemical of greatest interest in ALS is N-acetylaspartate (NAA), a compound found almost exclusively in neurons. When neurons die or become dysfunctional, NAA drops. In ALS, the most significant NAA reduction occurs in the motor cortex and corticospinal tracts.10PubMed Central. Magnetic Resonance Spectroscopy in ALS
One study measured a roughly 8% reduction in NAA concentration in the motor cortex of ALS patients compared to controls.11Journal of the Neurological Sciences. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis That may sound modest, but in a region that should be chemically stable, it is a measurable signal of neuronal distress. Separate work showed that NAA ratios were most markedly reduced in patients who had clear upper motor neuron involvement. Even patients who appeared clinically to have only lower motor neuron problems had some reduction in NAA ratios, hinting that the brain might be affected before clinical signs become obvious.12Archives of Neurology. Proton Magnetic Resonance Spectroscopy of the Primary Motor Cortex in Patients With Motor Neuron Disease: Subgroup Analysis and Follow-up Measurements
MRS is available on most clinical MRI scanners, but it requires specialized protocols and interpretation expertise that many imaging centers don’t routinely provide. Its value lies more in research settings and in specialized ALS clinics than in a general neurologist’s office.
The Tongue as a Window Into Bulbar ALS
One of the more unexpected MRI findings in ALS involves the tongue. In patients with bulbar-onset disease, where early symptoms include slurred speech and difficulty swallowing, the tongue undergoes dramatic structural changes that MRI can visualize. Early research comparing the tongues of ALS patients and controls found that the ALS tongue can shrink by as much as two-thirds in size, shift from its normal curved shape to a rectangular one, and lose its normal internal fiber architecture, appearing disorganized with areas of abnormal signal.13PubMed. Amyotrophic lateral sclerosis: abnormalities of the tongue on magnetic resonance imaging
As the tongue muscles die and are replaced by fat, the tissue brightens on certain MRI sequences. This has been called the “bright tongue sign,” and it reflects fatty infiltration consistent with neurogenic atrophy.14PubMed Central. Bright tongue sign as a radiological clue of bulbar onset amyotrophic lateral sclerosis: A case report A study evaluating tongue MRI more systematically found that the degree of signal change correlated with clinical bulbar function and was most severe in bulbar-onset patients.15NeuroImage: Clinical. Sonographic and 3T-MRI-based evaluation of the tongue in ALS For patients whose earliest complaint is trouble speaking or swallowing, tongue imaging can provide objective evidence of lower motor neuron damage in a region that electrodiagnostic testing sometimes struggles to assess thoroughly.
Muscle MRI Beyond the Tongue
The same logic applies to skeletal muscles throughout the body. When lower motor neurons degenerate, the muscles they supply develop edema and eventually replace with fat. Muscle MRI can detect both processes. In ALS, certain sequences reveal marked bright signals in lower limb muscles, a pattern distinct enough to help differentiate ALS from other motor neuron conditions.16PubMed Central. Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity A systematic review confirmed that researchers have used muscle MRI to assess signal changes, diffusion properties, volume loss, and fat infiltration in motor neuron diseases, though the techniques remain more common in research than in routine clinical practice.17PubMed. Muscle MRI in motor neuron diseases: a systematic review
Muscle MRI fills a gap that electromyography (EMG), the current gold standard for detecting lower motor neuron damage, cannot always address. EMG samples a limited number of muscles and is uncomfortable for patients. Muscle MRI can survey whole body regions in a single session, identifying subclinical involvement in muscles that haven’t yet caused symptoms. Whether it becomes a routine part of the ALS workup depends on cost, protocol standardization, and evidence that it changes clinical decisions rather than simply confirming what the neurologist already suspects.
Functional Connectivity and Network-Level Changes
Resting-state functional MRI (fMRI) takes yet another angle, measuring how different brain regions communicate with each other when a person is lying still. In ALS, functional connectivity is altered in both motor and extra-motor networks. Patients at the time of diagnosis showed reduced connectivity in motor and non-motor brain networks compared to healthy people. Patients who went on to progress quickly had even more disrupted connectivity at baseline, with decreased connections in sensorimotor, default mode, and frontoparietal networks, and increased connectivity in the salience network.18PubMed. Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study
A structural and functional connectivity study added nuance: while structural connections between motor regions were clearly damaged, the functional connections between left and right motor cortices were relatively preserved. However, within the patient group, stronger functional motor network interconnection paradoxically correlated with faster disease progression.19PLoS ONE. Motor Network Degeneration in Amyotrophic Lateral Sclerosis: A Structural and Functional Connectivity Study This is a counterintuitive finding and may reflect compensatory hyperactivity in a network that is structurally falling apart. Functional MRI is firmly in the research domain for ALS, but it highlights that the disease rewires the brain in ways that go far beyond the motor cortex.
When ALS and Frontotemporal Dementia Overlap
Up to half of ALS patients develop some degree of cognitive or behavioral change, and a significant minority meet criteria for frontotemporal dementia (FTD). MRI can help identify this overlap. A voxel-based morphometry study found that both ALS and ALS-FTD patients shared a common pattern of gray matter shrinkage in motor and premotor cortices, as well as in frontal and temporal regions. The frontal atrophy was markedly more severe in patients with the combined ALS-FTD presentation.20PubMed. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD
A more recent study looking at patients whose ALS-FTD began with cognitive symptoms versus motor symptoms found that the cognitive-onset group had gray matter volume reduction primarily in the limbic system. By contrast, the motor-onset group showed no significant gray matter reduction compared to controls at the time of assessment.21PubMed. Brain structural and perfusion changes in amyotrophic lateral sclerosis-frontotemporal dementia patients with cognitive and motor onset: a preliminary study Recognizing the ALS-FTD spectrum matters for prognosis, caregiving, and clinical trial eligibility. Brain MRI with volumetric analysis can flag frontotemporal involvement that bedside cognitive screening might miss.
How MRI Fits Into the Current Diagnostic Framework
ALS remains a clinical diagnosis. The most recent diagnostic criteria, the Gold Coast criteria, permit a diagnosis of ALS even without clear upper motor neuron signs, broadening the clinical definition and reducing diagnostic delay.22PubMed Central. ALS With and Without Upper Motor Neuron Signs: A Comparative Study Supporting the Gold Coast Criteria Under these criteria, the diagnosis rests on progressive motor impairment, evidence of lower motor neuron degeneration (typically from EMG), and the exclusion of other causes. MRI’s primary formal role is in that exclusion step. However, when an MRI does show positive findings like the motor band sign, corticospinal tract hyperintensity, or spectroscopic changes, they add supporting evidence that can increase a neurologist’s confidence and sometimes accelerate the diagnostic process.
One complication is specificity across motor neuron diseases. A study comparing white matter tract integrity in ALS and primary lateral sclerosis (PLS), a slower and rarer motor neuron disease, found identical patterns of corticospinal tract damage in both conditions.23PubMed Central. Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study MRI alone could not distinguish between them. Clinical context, disease tempo, and the presence of lower motor neuron signs remain essential for telling ALS apart from its close relatives.
Tracking Progression and the Search for Biomarkers
Beyond diagnosis, MRI has growing potential for monitoring how ALS progresses. Longitudinal imaging studies are better than single-timepoint scans at capturing the disease’s trajectory, and changes can be detected in as little as three months between scans.24PubMed Central. Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS An emerging pattern from repeat imaging is that white matter changes tend to appear early and then plateau, while gray matter loss continues relentlessly throughout the symptomatic phase. This has led to the suggestion that white matter measures may work best as diagnostic markers, while gray matter measures may be more useful for tracking how someone is doing over time.25PubMed. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration
Multimodal longitudinal studies, combining different MRI techniques in the same patients over multiple visits, have demonstrated that imaging can monitor cerebral degeneration in ways that complement clinical scales.26PubMed Central. Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis This is critical for clinical trials. If a new drug slows brain degeneration, imaging biomarkers could potentially show that effect faster than waiting for changes in clinical function scores, shortening trials and lowering costs.
Ultra-High Field MRI and Iron in the Motor Cortex
Most clinical MRI scanners operate at 1.5 or 3 Tesla. Research scanners at 7 Tesla offer dramatically higher resolution, enough to visualize individual layers of the cerebral cortex. In ALS, 7T imaging has revealed atrophy and abnormal dark signals in the deep layers of the primary motor cortex. One study reported a diagnostic accuracy of about 71% using these deep-layer findings, with the degree of signal abnormality correlating with upper motor neuron impairment and disease progression rate.27PubMed Central. High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis
What causes the dark signal? Post-mortem comparisons suggest it is iron accumulation. A combined 7T MRI and pathology study found marked signal abnormalities in the deeper motor cortex of ALS patients, and when those same tissue samples were examined under a microscope, the dark regions corresponded to areas of increased iron deposition.28PLoS ONE. Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology Quantitative susceptibility mapping at 7T confirmed that the dark signal co-localized with increased magnetic susceptibility in the middle and deep cortical layers.29PubMed Central. Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis These findings are exciting because they point to a specific biological process, not just a vague structural change. Whether iron accumulation is a cause or consequence of motor neuron death is still debated, but as a marker visible on imaging, it is unusually direct.
Machine Learning Applied to MRI Data
The human eye struggles to integrate dozens of subtle MRI measurements into a single diagnostic judgment. Machine learning algorithms can handle that complexity. One study using a machine learning pipeline on brain MRI data classified ALS patients with about 81% accuracy and distinguished between different motor phenotypes of the disease with nearly 93% accuracy.30Expert Systems with Applications. Machine learning-based radiomics for amyotrophic lateral sclerosis diagnosis A separate proof-of-concept study combining multiple MRI measurements into a neural network achieved area-under-the-curve values between 0.87 and 0.91, a range considered “good” to “excellent” for a diagnostic classifier. Texture data extracted from the images contributed the most to accurate classification.31PubMed Central. Multiparametric Microstructural MRI and Machine Learning Classification Yields High Diagnostic Accuracy in Amyotrophic Lateral Sclerosis: Proof of Concept
These accuracy numbers are impressive for a disease that has historically had no reliable imaging biomarker, but they come with important caveats. Most studies are single-center with relatively small patient groups, and performance tends to drop when algorithms trained at one site are tested on data from another. Variability in scanner hardware, imaging protocols, and patient populations all introduce noise. Before machine learning can move from research papers to a neurologist’s report, these tools will need large, multi-site validation studies and regulatory approval. Still, the direction is clear: the information needed to support an ALS diagnosis may already be embedded in MRI data, and algorithms are getting better at extracting it.